HighTower Advisors LLC Sells 49,888 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

HighTower Advisors LLC decreased its position in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 49.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 50,127 shares of the company's stock after selling 49,888 shares during the quarter. HighTower Advisors LLC owned 0.09% of Astrana Health worth $1,581,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Moran Wealth Management LLC lifted its stake in shares of Astrana Health by 21.5% during the fourth quarter. Moran Wealth Management LLC now owns 7,944 shares of the company's stock valued at $250,000 after acquiring an additional 1,404 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Astrana Health by 348.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,788 shares of the company's stock valued at $1,191,000 after purchasing an additional 29,355 shares during the period. Victory Capital Management Inc. boosted its stake in shares of Astrana Health by 38.6% in the 4th quarter. Victory Capital Management Inc. now owns 62,116 shares of the company's stock valued at $1,959,000 after purchasing an additional 17,310 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Astrana Health by 5.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company's stock worth $14,861,000 after buying an additional 23,533 shares during the last quarter. Finally, US Bancorp DE lifted its stake in shares of Astrana Health by 3,880.0% in the 4th quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after purchasing an additional 4,656 shares during the period. 52.77% of the stock is owned by institutional investors.

Remove Ads

Astrana Health Stock Down 2.6 %

Shares of NASDAQ ASTH traded down $0.82 during mid-day trading on Friday, hitting $30.54. The company had a trading volume of 272,651 shares, compared to its average volume of 262,037. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a 50-day simple moving average of $33.85 and a two-hundred day simple moving average of $41.99. The company has a market capitalization of $1.53 billion, a PE ratio of 23.49, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. Astrana Health, Inc. has a one year low of $23.12 and a one year high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million. On average, equities analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current year.

Analysts Set New Price Targets

ASTH has been the topic of several recent analyst reports. Truist Financial reduced their price objective on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th. Stifel Nicolaus lowered their price objective on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Robert W. Baird reduced their target price on Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. Bank of America reduced their price target on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a report on Tuesday, March 4th. Finally, Macquarie raised Astrana Health to a "hold" rating in a research report on Monday, December 16th. Two analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Astrana Health currently has a consensus rating of "Moderate Buy" and an average price target of $56.17.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.